New no-part-change labeling system delivers faster changeovers, higher OEE, and improved operational efficiency for pharmaceutical manufacturers and CDMO environments.

IL Group, a specialist in multifunctional labeling solutions for the pharmaceuticals and healthcare sectors, has announced the launch of the SMCL Series RC-506E Single Minute Changeover Labeler, a next-generation pharmaceutical labeling solution designed to reduce changeover complexity, minimize downtime, and improve production efficiency through automated setup and no-part-change operation.

The newly released RC-506E is smaller and more versatile than the company’s RC-506, accommodating a broader range of container sizes and enabling frequent format changes and smaller-batch production. Designed for pharmaceutical manufacturers, clinical trial production, and CMO/CDMO operations, the RC-506E eliminates the need for replacement parts during product changeovers, which is one of the industry’s most time-consuming challenges. This makes it especially well-suited for investigational drug production and smaller-scale, flexible manufacturing environments.

Through an intuitive interface and automated setup, operators can complete format transitions in as little as 10 minutes while maintaining consistent labeling accuracy and performance. Engineered to maximize Overall Equipment Efficiency (OEE), the system reduces downtime, increases uptime, and supports high-quality output across pharmaceutical packaging operations.

“The RC-506E represents IL Group’s continued focus on solving real production bottlenecks within pharmaceutical manufacturing,” said Emilia Vitor, Group Marketing Manager at IL Group. “By removing replacement parts from the changeover process and automating critical setup functions, manufacturers can improve operational flexibility while reducing human error and increasing throughput.”

The RC-506E automates key labeling processes to deliver consistent, repeatable performance while minimizing manual intervention. By simplifying setup, the system helps operators avoid common changeover errors and supports reliable production in highly regulated environments.

Designed for vial applications, the labeler offers a processing capacity of up to 100 units per minute and supports container diameters ranging from 16.0 mm to 50.0 mm. Its compact footprint – 10’(L) × 8’(W) × 6’2” (H) – allows for efficient integration into existing pharmaceutical packaging lines.

For more information visit: https://www.group-il.com/en/resources/labeling-machines/smcl/  

About IL Group

Based in Aichi, Japan IL Group is a total pharmaceutical packaging solution provider. The company provides precision, often customized labeling solutions for global pharmaceutical and healthcare companies. In addition to its advanced pharmaceutical labeling solutions, IL Group provides clinical trial services, contract packaging services, and a series of high-efficiency labeling machines. Its extensive portfolio includes ISO-compliant roll-on and shrink-tack labels featuring value-added benefits such as tamper evidence, protection against breakage, and light-shielding properties, as well as specialty constructions whose functions range from reliable adhesion in cryogenic applications to detachable elements for ease of medical recordkeeping.

IL Group’s US entity, Iwata Label USA, combines elevated Japanese quality standards with a keen sense of North American market needs. In Japan, IL Group holds the predominant share of Japan’s pharmaceutical labeling market. Through its three-pole network in the US, Europe, and Japan, as well as various global partnerships, IL Group is poised for further growth and innovation. For more information, visit http://www.group-il.com/en.

The above text is a press release by IL Group. It was featured in multiple pharma news sites. Below are links to those articles.

Material Handling Wholesaler

Label and Narrow Web

Sustainable Packaging News

Healthcare Packaging

Packaging Connections

WhatTheyThink.com

Converter Magazine

Contract Pharma

Introduction

The BIO International Convention is one of the world’s largest gatherings for the biotechnology community, bringing together pharmaceutical companies, emerging biotech, investors, and research organizations. 

From June 22–25, 2026, the event returns to San Diego, creating a space where scientific progress meets business development and global partnership. 

This year, IL Group will continue strengthening its engagement with the pharmaceutical sector. At BIO 2026, the company will focus on how advanced packaging and labeling technologies can support safer, more efficient, and scalable drug delivery.

 What IL Group will Showcase at BIO 2026

IL Group will highlight its multi‑functional labeling solutions, designed to address several key challenges in today’s pharmaceutical landscape: 

• Product protection against physical damage and light exposure 

• Occupational safety through VPP (Vial Protective Packaging), reducing exposure to hazardous drugs 

• Ultra‑low temperature labeling for biologics, ensuring stability throughout cold‑chain storage and distribution 

These technologies are positioned as essential tools that help maintain drug quality and support safe, reliable distribution across global markets. 

Integration with Automation and Manufacturing Solutions

In addition to labeling materials, IL Group will introduce its SMCL Series of automatic labeling machines, designed for highly flexible operations.   

They are particularly well‑suited for: 

• CDMOs 

• 503B outsourcing facilities 

• Biotech companies managing diverse product pipelines 

Key capabilities include efficient multi-product, small-lot operations, automatic changeovers that reduce downtime and operator workload, and seamless compatibility between labeling materials and equipment. 

Through these offerings, IL Group aims to explore new collaborations with CDMOs and pharmaceutical manufacturers while demonstrating scalable approaches that align with evolving production models. 

Reference: https://www.group-il.com/en/resources/labeling-machines/smcl/ 

From Practical Applications to Scientific Validation

At the exhibition, IL Group will present both hands‑on examples and the science behind its technologies: 

• Practical applications → Case studies from U.S. customers showing how IL Group’s solutions are already being used in real manufacturing environments 

• Scientific and technical validation → Research findings, including published studies on VPP, that explain the material behavior and performance 

By combining real‑world results with technical evidence, visitors can gain a clear understanding of both how the solutions work and why they work.

Conclusion

At BIO International Convention 2026, IL Group looks to engage with the global biotechnology and pharmaceutical community while demonstrating how advanced labeling and packaging technologies can support the future of drug manufacturing. By combining protective labeling materials, ultra-low temperature solutions, and flexible automation systems, IL Group aims to address the growing demands for safety, efficiency, and scalability across the pharmaceutical industry. Through both practical customer applications and scientific validation, visitors can find solutions that help them adapt to increasingly complex production environments.

Exhibition Overview 

Event Name: BIO International Convention 2026 
Dates: June 22 (Mon) – June 25 (Thu), 2026 
Booth: 5456
Venue: San Diego Convention Center, USA 
Official Website: BIO International Convention 

We look forward to meeting many visitors in San Diego. Please feel free to stop by our booth. 

 

 

You might also like

In pharmaceutical manufacturing, labeling is a critical process that directly affects productivity, quality, and compliance.

Many production lines continue to rely on manual or semi-manual labeling, even as product variations increase, and operational complexity grows. Often, they are unaware of how much waste and risk is embedded in the process.

The SMCL RC-506E is an automatic labeler developed to address these challenges.
In this video, we walk through the typical issues faced on labeling lines and show how RC-506E helps create a more stable, efficient, and visible operation.

Common Challenges in Pharmaceutical Labeling Lines

The video begins by visualizing problems that are familiar to many production managers:

• Frequent changeovers that reduce effective operating time
• An increasing number of labels and packaging specifications, making management more complex
• Dependence on operator skill, resulting in variability
• Human errors, such as mislabeling or setup mistakes
• Workplace safety risks caused by manual adjustments

These issues often accumulate quietly, making it difficult to understand where losses are occurring.

How SMCL RC-506E Addresses These Issues

The SMCL RC-506E is a fully automatic labeling machine designed to support both efficiency and operational stability.

1. Stable Automatic Labeling

The system automates key labeling processes, reducing reliance on individual operator skills, and ensuring consistent performance, even as the number of product variants increases.

2. Changeover Efficiency

By supporting flexible label and container changes, RC-506E minimizes downtime associated with frequent changeovers, which is increasingly important in modern pharmaceutical production.

3. Error Prevention Through Automation

Automation helps reduce labeling errors caused by manual handling or judgment, contributing to higher quality and compliance.

4. User-Friendly Operation Interface

The machine is designed with an intuitive interface that supports setup and operation, helping standardize work across shifts and operators.

From “Unseen Waste” to Measurable Improvement

One of the video’s key messages is that many labeling line inefficiencies remain invisible.

Time losses, minor stops, rework, and overreliance on experience are often accepted as unavoidable simply because they are not quantified.

SMCL RC-506E is positioned not just as a machine, but as a tool to help manufacturers rethink how labeling efficiency is evaluated and improved.

 

Learn More About RC-506E

Find detailed information about RC-506E, its applications, and related labeling solutions on our website.

 

Have questions about automating your labeling process?

Our specialists can help you review your current line,

identify potential inefficiencies, and discuss whether SMCL RC-506E is the right fit for your production environment.

 

 

You might also like

In this article we introduce the video: 

This video, titled “A Look at Our Jobs,” provides a closer look at the daily work of members in the Manufacturing Department. 

It features three members from different departments: 

• Printing Section 

• Processing Section 

• Production Engineering Section 

Through their daily work, they share what their responsibilities involve, what challenges they face, and what gives them a sense of accomplishment. 

Although each role is different, all three employees share the same goal: delivering pharmaceutical labels that our customers can trust. 

Printing Section: Where Quality Begins 

The Printing Section is responsible for producing labels that meet strict pharmaceutical standards. 

Their work requires: 

• Maintaining precise print quality, including color and alignment 

• Continuously monitoring and adjusting printing conditions 

• Ensuring consistency across all production runs 

The featured member shared how experience has helped build confidence over time. While some products felt difficult at first, repeated daily experience allowed the work to become more natural. 

Processing Section: Precision and Craftsmanship 

In the Processing Section, printed materials are converted into finished labels. 

This process requires: 

• High attention to detail during splicing of labels 

• Strict quality control to prevent defects 

• Careful packaging and bagging of finished products 

The member featured in the video explained that the strongest sense of accomplishment comes from successfully completing a difficult project together with the entire team. 

They also emphasized the supportive atmosphere within the department. Team members help one another whenever support is needed, creating a workplace environment built on cooperation and communication. 

Production Engineering Section: Driving Improvement 

The Production Engineering Section supports manufacturing by improving processes and solving operational challenges. 

Their responsibilities include: 

• Enhancing production efficiency 

• Supporting equipment and system changes 

• Planning and completing detailed verification processes  

The featured employee shared that one memorable experience was participating in a trade show, where they had the opportunity to answer customer questions directly. This experience helped broaden their understanding beyond the Manufacturing Department. 

Their role is key in enabling continuous improvement across the entire manufacturing process. 

Conclusion 

This video shows that IL Group’s strength lies not only in its technology, but also in its people.  Across all three roles, several common themes stand out. Each member demonstrates a strong sense of responsibility for maintaining quality and ensuring that every product meets strict standards. They take pride in the precision and craftsmanship required in their work, while continuously looking for ways to improve processes and performance. Above all, they share a strong sense of accomplishment when production is completed successfully without errors, knowing their work contributes directly to safe and reliable pharmaceutical products. 

Learn More 

For more information about careers, check our careers page.
https://www.group-il.com/en/careers/ 

For more information about IL Group, please download the company brochure:
IL Group Company Pamphlet

 

 

You might also like

Introduction 

IL Contract Packaging Co., Ltd. is a new business entity within IL Group that specializes in contract pharmaceutical packaging services while keeping the DNA of IL Group. 

The company provides integrated services from packaging design to contract packaging, storage, and logistics for pharmaceuticals, quasi-drugs, cosmetics, and food products. We interviewed the company, which continues to be at the forefront of supporting “medicine safety” by responding to diverse needs with its unique packaging technology, leveraging its global-level quality control system. 

From “IL Pharma for labels” to “IL for contract packaging” 
Breaking through the limits of a small sales force, a digital strategy to be “selected” in the age of AI search. 

“What is IL?” Starting from the Ground Up. The Influence of an Overly Strong Parent Company and the Challenges of a New Company 

The company was established in April 2022 as a company specializing in contract packaging as part of Iwata Label’s shift to a holding company structure. Despite being unique in terms of pharmaceutical packaging, its launch was also a battle against the “barrier of recognition.” 

“Within the industry, the association between ‘Iwata Label’ and ‘labels and labeling machines’ was so strong that, even after a year and a half, not only was the new company name largely overlooked, but the fact that the group was operating a contract packaging business was virtually unknown,” says Mr. Nagao. He adds that after the company name changed from “Iwata Label” to “IL (Iwata Label),” it was not uncommon for first-time customers to say, “I have no idea where a company with an alphabetical name is located.” 

At the time, Mr. Nagao was the sole sales representative. There were physical limitations to covering pharmaceutical companies nationwide on his own, and relying solely on the company website for communication had its limits; therefore, a new “entry point” was essential for reaching potential customers across the country.

Maximizing Sales Efficiency Through a “Noise-Free” Website

Where should we focus our limited resources? What Mr. Nagao sought from iVEXL was not merely exposure, but “high-quality matching.” 

“While we post content on social media across the entire group, it’s difficult to raise brand awareness through our corporate website alone. The key feature of iVEXL is that it’s a highly specialized site focused exclusively on the life sciences. We believed that many visitors come here with a clear purpose in mind when searching for information. It’s a place where professionals—who are often too busy with their daily work to find time for research—come to search for specific information. They expect a level of clarity and focus that’s simply not available in content aimed at a general audience.”

In the first year of our listing on iVEXL, our average web traffic—including visits to our own website—doubled compared to before the listing. As the rise of AI search makes it increasingly difficult to drive traffic to our own site, iVEXL has become a “second sales channel” for us. 

The Importance of “Planting Your Flag on the Platform” in the Era of SGE and AI Search

In the interview, Mr. Nagao offered important insights into modern web marketing. 

“We’re now in an era where AI search engines like Google’s SGE provide answers without users even visiting a website. A young representative who contacted us after browsing the web once told me, ‘I searched using AI, and your company came up third.’ We’ve entered an era where, beyond Google searches, people use AIs to narrow down trustworthy companies based on their compiled responses. That’s precisely why I believe that placing your information firmly on a trustworthy platform and ensuring it can be found by AI creates an opportunity to foster an understanding of your ‘character’ and build trust.”

＊【 Glossary: What is SGE (Search Generative Experience)? 】 

This refers to a new feature on Google search results pages where generative AI summarizes and presents answers. Its key feature is that users can find the information they need directly on the search results page without having to click through to a website. While this poses a risk for companies that their websites may no longer be viewed directly, ensuring that accurate information is stored on platforms (such as iVEXL) that the AI cites as “reliable sources” has become more crucial than ever for building brand awareness and trust. 

The “Invisible Value” Behind a Single Inquiry

Mr. Nagao also spoke highly of the quality of a “single inquiry.” 

“While there are cases where we receive concrete inquiries through the iVEXL system, it seems there are also many instances where customers who obtained information via iVEXL choose to call us directly or contact us through the web form on our company website. I feel that iVEXL is not only serving as a starting point for customers to learn about our company—or, in other words, creating touchpoints with customers—but is also building a ‘foundation of trust’ that cannot be measured solely by the number of direct deals closed.” 

Regarding the support provided by the admin team, he also praised iVEXL’s partnership-based approach, noting, “Managing operations while conducting sales is challenging, but their responses are quick, and we receive timely support. They also propose opportunities to exhibit at online trade shows, so we can implement initiatives without hesitation.” He acknowledged that this hands-on support has become a key asset for our “small sales team.”

Driving Business Decisions with Data: How to Use Access Reports

The monthly access reports are utilized as key metrics that underpin the company’s sales strategy, such as in President Noda’s reports to the board of directors. 

While iVEXL has received requests for further improvements—such as enhancing the readability of the reports and providing analytical consultations that delve deeper into the context behind the numbers—the way these reports are utilized is highly sophisticated. Mr. Nagao independently analyzes the report data and presents internal reports that add value, such as tracking “trends in page views following strategy updates.” 

The results of web initiatives—which cannot be fully measured by direct inquiry counts alone—are demonstrated through objective data, such as “a doubling of traffic from the first to the second year.” This accumulation of data serves as powerful evidence for gaining internal understanding and buy-in. 

Future Outlook: From Packaging Design to Contract Packaging. Maximizing Group Synergies and Global Expansion

IL Contract Packaging’s future prospects extend far beyond Japan. President Noda stated, “Our strength lies in holding a pharmaceutical manufacturing license covering packaging, labeling, and storage. We are focusing our efforts not only on the domestic market but also on providing services to foreign clients who do not have manufacturing bases in Japan. Centered on the functional secondary packaging technology of our group company, IL Pharma Packaging, we will actively expand integrated services—from packaging design to contract packaging—by leveraging group synergies.  

Just the other day, a company received an inspection from the U.S. FDA. Our greatest asset is a packaging design and contract manufacturing system capable of withstanding such stringent global regulations,” he stated emphatically. 

He also expressed his hope that iVEXL will evolve from a mere “showcase” into a platform that “connects” companies through events and business matching, serving as an engine to propel our technology onto the global stage.

In today’s increasingly digital world, where the way we search for information is constantly evolving,  iVEXL believes the key lies in “how effectively we can convey a company’s strengths in their purest form.” With this in mind, iVEXL is not merely a venue for publishing information, but a platform designed to foster deep connections among life sciences industry experts. Through initiatives such as online exhibitions, they continue to create an environment where the technologies of our listed companies are properly recognized by the market. 

iVEXL remains committed to supporting the business growth of companies with advanced technical capabilities, such as IL Contract Packaging. 

 

 

 

You might also like

Introduction 

INTERPHEX Week Tokyo 2026 brings together pharmaceutical and biotechnology leaders focused on improving efficiency, quality, and scalability in manufacturing. 

Yet one challenge continues to limit performance across many production lines: hidden inefficiencies. 

Time loss, excessive manual handling, and inconsistent operating speeds often go unnoticed, but their impact is measurable. 

At the IL Group booth, we make these inefficiencies visible through data and show how they can be reduced. 

Turning Hidden Inefficiencies into Measurable Improvements 

At this year’s exhibition, IL Group will demonstrate how labeling operations can be optimized through automation and reduced reliance on manual processes, featuring our latest SMCL Series labeling systems. 

 

Free On-Site Line Efficiency Check 

At the booth, we will offer a simple on-site diagnostic of your current labeling or packaging line.
In just a few minutes with our specialists, you will receive insights into: 

• Where time and labor are being lost 

• Which processes are suitable for automation 

• How SMCL systems can improve throughput and stability 

 

You will receive immediate, practical insights based on your current operation. 

A dedicated leaflet explaining this quick diagnosis service will be distributed exclusively at the booth. 

SMCL Series: Designed for Smart Automation 

The SMCL Series is engineered to support pharmaceutical manufacturers facing labor shortages and increasing compliance requirements. 

Key highlights include: 

• Flexible integration into existing production lines 

• Stable performance for high-mix, low-volume production 

• Automation-ready design for long-term scalability 

Our team will walk you through real use cases and help identify how the SMCL Series fits into your operation. 

Contract Packaging Services 

In addition to our labeling technologies, IL Group also offers contract packaging services through IL Contract Packaging, specializing in GMP compliant secondary packaging for pharmaceutical products. Our operations are designed to support high mix, low volume production environments, including commercial, clinical trial and sample packaging. Capabilities include visual inspection, precision labeling, kitting, and final packaging, all managed under a controlled quality system. By integrating these services with our functional labeling technologies, we deliver integrated solutions that enhance product protection, maintain quality, and support a seamless transition from development to commercialization. 

 

Exhibition Overview 

Event Name: INTERPHEX Week Tokyo 

Dates: May 20–22, 2026  

Venue: Makuhari Messe  

Booths: 

• IL Group: 34-6 (INTERPHEX JAPAN) 

• IL Contract Packaging: 18-39 (CMO/CDMO Expo)  

 

Stop guessing where inefficiencies are. 

 

Visit our booth to see your challenges quantified and discover how automation can unlock measurable improvements in your labeling operations. 

Secure a consultation slot during the exhibition to receive tailored insights and a small gift.

 

 

You might also like

1. Introduction
Each April, INTERPHEX in New York brings together pharmaceutical and biotechnology professionalspharmaceutical and biotechnology professionals to explore technologies shaping the future of drug manufacturing and delivery.

Following a strong presence last year, IL Group will once again participate in the 2026 exhibition, presenting solutions designed to enhance the safety and integrity of pharmaceutical packaging.

2. Last Year’s Foundation
At INTERPHEX 2025, IL Group introduced its multi-functional labeling approach for vials and syringes—focusing on improving protection without requiring major changes to existing packaging systems.

These solutions addressed key industry challenges such as:

• Physical protection against cracks and breakage
• Light protection for photosensitive formulations
• Occupational health related dangers

The approach gained strong industry attention and was featured in an interview with PHARMTECH, later published as both an article and a video, reinforcing its relevance in the field.

The full interview, including the video, can be viewed here:

https://www.pharmtech.com/view/interphex-2025-functional-labeling-protect-parentals-vials-syringes

3. What Remains Central This Year / What’s New
At INTERPHEX 2026, IL Group will continue to strengthen the value proposition of our multi-functional labels suchas packaging solutions for high value drugs and light sensitive drugs, while also introducing insights from a recently published research paper.

At this event, we will introduce our Single-Minute Changeover Labeling Machine.

The exhibit will highlight practical ways to implement solutions, compatibility with existing manufacturing processes, and the balance between performance enhancements and operational barriers. The focus remains on demonstrating reliability, scalability, and real-world applicability.

In addition, the newly published paper reinforces this value proposition by providing scientific data that validates the technologies on display, offering deeper analysis of performance and material behavior, and connecting research outcomes with practical use cases.

As a result, visitors can gain not only a product-level understanding, but also a clearer view of the underlying technical rationale.

4. Conclusion
By combining functional solutions with newly published research, IL Group’s presence at INTERPHEX 2026 reflects a progression from industry recognition to deeper technical substantiation.

For attendees, this creates an opportunity to:

• Revisit solutions that have already gained attention
• Explore their practical implementation in greater depth
• Understand the evolving technical foundation behind them

In a field where reliability and evidence are critical, this integrated approach offers meaningful value to both technical and business audiences.

■ Exhibition Overview
Event Name: Interphex NY

Dates: April 21 (Tue) – April 23 (Thu), 2026

Venue: Javits Center, New York City

Booth Number: Booth 2967 (Iwata Label USA)

Official Website: https://www.interphex.com/en-us/show-info.html

We sincerely look forward to welcoming many visitors. Please feel free to stop by our booth.

 

 

 

 

You might also like

We are pleased to announce our participation in Pharmapack Europe 2026, Europe’s leading exhibition dedicated to pharmaceutical packaging, drug-delivery systems, and medical-device packaging technologies. The two-day event attracts pharmaceutical manufacturers, packaging specialists, engineers, and global innovators shaping the next generation of drug-delivery and packaging solutions.

Dates: 21–22 January 2026
Location: Paris Expo, Porte de Versailles, Hall 4, Paris, France
Booth: 4K43

Our 2026 Showcase
At Booth 4K43, we will highlight two types of solutions:

CP-31 Demonstration Unit
Our CP-31 system represents the next evolution in compact, high-precision pharmaceutical labeling. The demo unit at Pharmapack will show in real time:

• Stable shrink tack labeling performance
• Smooth integration into various pharmaceutical packaging workflows
• Compact design optimized for modern production environments

Visitors will be able to observe live operation and engage directly with our engineering team regarding implementation, customization, and performance optimization.

 

 

 

 

 

Functional Pharmaceutical Packaging Labels
We will also present our latest line of functional pharmaceutical labels engineered to elevate product protection, patient usability, and operational efficiency. Key features include:

• Enhanced durability and performance in light-sensitive workflows
• Compliance-ready solutions for global regulatory environments
• Customizable designs supporting serialization, tamper evidence, and safety-critical applications

These labels reflect our commitment to delivering packaging solutions that enhance patient safety, operational assurance, and product integrity.

 

 

 

Overview of Pharmapack Europe 2026

 

 

 

Pharmapack Europe 2026 continues to serve as a comprehensive platform for discovering global advancements in pharmaceutical packaging and device delivery. Attendees will experience:

• Extensive exhibitor showcase featuring primary/secondary packaging, sterile and barrier solutions, medical-device packaging, labeling technology, and contract packaging services.
• In-depth programs & educational content focused on regulatory updates, sustainability, smart automation, and evolving drug-delivery technologies.
• Exceptional networking opportunities with more than 6,000 attendees and 400+ companies from over 90 countries.

This event provides a unique environment for industry professionals to identify solutions that enhance safety, efficiency, and patient-centric design across the pharmaceutical supply chain.

Join Us in Paris — Pharmapack Europe 2026

 

 

 

 

 

 

We look forward to welcoming customers, partners, and industry peers at Booth 4K43. Our team is excited to demonstrate our 2026 technology lineup and discuss how our solutions can support your pharmaceutical packaging and drug-delivery challenges.
We hope to see you in Paris this January.
You can register for a free badge through this link.

 

 

 

 

You might also like

IL Group Showcases Cutting-Edge Pharmaceutical Labeling & Packaging at INTERPHEX JAPAN 2025

This year IL Group exhibited at INTERPHEX JAPAN 2025, one of Asia’s premier events for pharmaceutical manufacturing and packaging innovation. Held at Tokyo Big Sight, the three-day tradeshow brought together global pharmaceutical leaders, technology providers, engineers, and innovators shaping the future of life sciences.

Dates: July 9-11, 2025
Location: Tokyo Big Site, Japan

Our team exhibited and showcased our industry-leading pharmaceutical labeling solutions across two booths, W11-34 and W4-37, offering a first-hand look at our latest advancements in pharmaceutical labeling, high-precision packaging technologies, as well as our contract packaging services for small-lot and imported pharmaceuticals.

Interphex Japan kicked off with energy and excitement as attendees explored new technologies designed to elevate efficiency, reliability, and compliance in pharmaceutical production. Our team dedicated significant preparation to highlight the latest IL Group systems, and we were very excited to welcome visitors and industry partners from across Japan and around the world.

From automatic labelers to advanced labeling systems, visitors learned how IL Group empowers pharmaceutical manufacturers to meet global regulatory standards while optimizing throughput and product quality.

Collaboration, Innovation & Industry Connections

Across the three-day event, our booths were filled with meaningful conversations around:
• Optimized labeling workflows
• Digitalization and smart automation
• Ensuring accuracy and compliance in pharma production
• Solutions designed for Japanese and global standards

It was inspiring to connect with professionals dedicated to innovation in patient safety, product integrity, and pharmaceutical supply-chain excellence. To everyone who visited us, thank you. We deeply appreciate the conversations, collaboration, and opportunity to share our latest technologies. IL Group remains committed to advancing the future of pharmaceutical labeling and packaging, and events like INTERPHEX JAPAN continue to fuel our drive for innovation and excellence.
We look forward to reconnecting with our partners, customers, and industry peers at next years event.

 

Looking Ahead: INTERPHEX JAPAN 2026

We’re already begun preparing for next year’s event, taking place during INTERPHEX Week Tokyo / Regenerative Medicine Expo Tokyo.

Dates: May 20–22, 2026
Location: Makuhari Messe, Japan

We can’t wait to continue showcasing new solutions that support global pharmaceutical manufacturing. Stay tuned for updates on our 2026 technology lineup and booth details, we hope to see you there!

 

You might also like